Claim
Search Awardees

Sparsha Pharma Usa LogoSparsha Pharma Usa

UEI: NCWDWN5LC315 • CAGE: 8SHK6

Overview

Awardee Type
Parent
Federal Capability Statement
Sparsha Pharma USA, Inc. is a pharmaceutical company located in Oceanside, California that specializes in transdermal/topical, and oral/sublingual film products. Sparsha has the capability to take products from formulation development to commercial production. Sparsha currently produces the Lidocaine 4% Patch (Over the counter) under Current Good Manufacturing Practice (cGMP).
Keywords
Pharma, medical, transdermal, topical, GMP, patch, lidocaine, controlled substance, pain, extended release, DEA, R&D, manufacturer, FDA, CRO, film, manufacturing, San Diego, CA, Oral film, sublingual, topical anesthetic and analgesic, Niravi24hours, OTC
SBA Special Equipment
Coating machine, Cut/Pack machine, Cartoning/serializing machine
Website
https://www.sparshausa.com
Headquarters
Oceanside, CA
United States
Federal recipient SPARSHA PHARMA USA, INC. dba SPARSHA PHARMA USA INC (UEI NCWDWN5LC315, CAGE 8SHK6) is headquartered in Oceanside CA. Its primary registered NAICS is 325412 Pharmaceutical Preparation Manufacturing. The corporation was founded in June 2012 and federally registered in October 2020.

Federal Registration and Certifications

Legal Name
SPARSHA PHARMA USA, INC.
DBA
SPARSHA PHARMA USA INC
Division Name
SPARSHA PHARMA USA
UEI
NCWDWN5LC315
CAGE Code
8SHK6
Primary NAICS
325412 - Pharmaceutical Preparation Manufacturing
SBA Certifications
None
Self Certifications
Minority Owned Business
Self-Certified Small Disadvantaged Business
Subcontinent Asian (Asian-Indian) American Owned
Entity Structure
Corporate Entity (Not Tax Exempt)

People

Vendor contacts at Sparsha Pharma Usa

Subscribe to find 500K+ key government decision markers

Free Trial Schedule Demo